发明授权
- 专利标题： Heterobicyclic compounds useful as kinase inhibitors
- 专利标题（中）： 用作激酶抑制剂的异双环化合物
-
申请号： US13084622申请日： 2011-04-12
-
公开(公告)号： US08309571B2公开(公告)日： 2012-11-13
- 发明人: T. G. Murali Dhar , Stephen T. Wrobleski
- 申请人： T. G. Murali Dhar , Stephen T. Wrobleski
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Laurelee A. Duncan; Pamela A. Mingo
- 主分类号： A01N43/42
- IPC分类号： A01N43/42 ; A61K31/44 ; C07D413/00
摘要：
A compound of Formula (I) and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase.
公开/授权文献
- US20110190292A1 HETEROBICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS 公开/授权日：2011-08-04
信息查询
IPC分类:
